Emergent BioSolutions, Inc. (EBS) Tops Q4 EPS by 11c; Reaffirms FY11 Outlook
Emergent BioSolutions, Inc. (NYSE: EBS) reported Q4 EPS ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
